Episurf Medical Converts Convertible Bonds to Shares
Episurf Medical AB has converted convertible bonds with a nominal value of SEK 9.3 million into 206.2 million Class B shares. The conversion is related to the acquisition of the Hudiksvall portfolio.
Episurf Medical AB (publ) has converted convertible bonds with a nominal value of SEK 9,279,911 into 206,220,244 Class B shares. The conversion occurred at the request of the holders of the convertible debentures.
This conversion is linked to the acquisition of the Hudiksvall portfolio, which closed on October 1, 2026. At that time, Episurf issued convertible bonds totaling SEK 64,780,000.
The conversion increases the number of Class B shares and votes in Episurf. The conversion price was set at SEK 0.045 per share, as per the bond terms and conditions.
Episurf Medical is a medical technology company focused on orthopedic implants.